NTRK1 and central nervous system cancer: Gene fusions of the neurotrophic receptor tyrosine kinase (NTRK) that code different tropomyosin receptor kinase (Trk) members of the receptor tyrosine kinase (TRK) family act as oncogenic drivers for several tumors, especially in children and rarely (<2%) including high-grade gliomas [193,194,195,196].